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Abstract: A mucinous adenocarcinoma of the thymus is rare, and
there is presently limited information on the clinical aspects of this
uncommon type of tumor. Only six cases have been reported in the
literature. A 49-year-old Japanese male presented with an anterior
mediastinal mass, and underwent a tumor resection. Histologically
the tumor consisted of a mucinous adenocarcinoma with pleural
dissemination. Postoperative radiotherapy and chemotherapy were
performed. The patient is still alive with pleural dissemination 11
months after surgery.
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Thymic carcinoma is a relatively rare neoplasm. In addi-tion, a primary mucinous adenocarcinoma of the thymus
is extremely rare,1–5 and it has not yet been classified by the
World Health Organization criteria. This report describes a case
of mucinous adenocarcinoma with multimodal treatment.
CASE REPORT
A 49-year-old Japanese male visited our hospital com-
plaining of pain in the left shoulder. Chest computed tomog-
raphy demonstrated a well-circumscribed mass in the anterior
mediastinum (Figure 1). The tumor, measuring 8.5 cm in size,
presented as a focal heterogeneously enhanced mass with
partial calcification. The large part of the tumor was adjacent
to the pericardium, and involved the left brachiocepharic
vein. Radiologically, there was no lesion in the lung paren-
chyma. Chest magnetic resonance imaging showed the tumor
lacked a capsule and focal high intensity with T2 weighted
images. Laboratory data showed no abnormalities such as an
elevation of the serum tumor markers. The patient was
preoperatively diagnosed to have either an invasive thymoma
or thymic carcinoma, and therefore underwent a tumor resec-
tion by surgical procedures. During the operation, the tumor
was found to be a firm solid mass that extensively adhered to
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FIGURE 1. A contrast enhanced CT scan shows a solid
mass containing a small region of calcification in the anterior
mediastinum with heterogeneous enhancement.
FIGURE 2. The photograph shows the cut-surfaces of the
resected tumor. The surfaces were milky white.
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the pericardium, while also demonstrating pericardial dissem-
ination. Although the left phrenic nerve was involved, the left
brachiocepharic vein was not invaded. A tumor resection was
thus performed and the pericardium was repaired. The dis-
ease was judged to be Masaoka’s stage IVb.6 Macroscopi-
cally, the resected tumor measured 10 cm in size, it was solid
with an irregular margin and a capsule. The cut-surface was
white-milky with abundant mucin (Figure 2). Microscopi-
cally, the tumor cells had hyperchromatic and round nuclei.
Scattered clusters of cells floated in pools of extracellular
mucin (Figures 3A, B). The mass had a small portion of
glandular formation and a stroma. The tumor cells were
immunohistochemically positive for cytokeratin 7 and cyto-
keratin 20, negative for thyroid transcription factor-1 and
Cluster of Differentiation 5 (DAKO CA). The pathologic
diagnosis of the tumor was a mucinous adenocarcinoma of
the thymus. The patient had sequential postoperative chemo-
therapy with adriamycin, cisplatin, vincristin, and cyclophos-
phamide (ADOC) after irradiation of the mediastinum (60
Gy). Eleven months later, the patient was alive with aggres-
sive pleural dissemination.
DISCUSSION
In thymic epithelial tumors, thymic carcinoma is com-
paratively rare. The reported frequency is 19.3 to 21.3%.7
Primary mucinous adenocarcinomas of the thymus are ex-
tremely rare with only six cases reported in the literature.1–5
Thymic carcinoma is rare so it is necessary to first exclude
metastatic and another primary lesions. Although the current
case was examined in detail, there was no evidence of lesions
elsewhere. Recently, improved immunohistochemical obser-
vations have been found to be useful for the differential
diagnosis of these tumors. In previous reported cases, they
used immunohistochemical examinations and the results
showed either weak or diffuse staining for CD 5 in 4 of the 5
cases (Table 1). However, Kapur et al.2 described that CD 5
is not conclusive for primary thymic adenocarcinoma. There-
fore, although the tumor cells were immunohistochemically
negative for CD 5, the patient was diagnosed to have a
primary mucinous adenocarcinoma of the thymus based on
the pathologic and the other immunohistochemical findings.
Due to the fact that this disease is rare, it is impossible
to conduct randomized control trials, therefore treatment for
thymic carcinoma has not yet been established. Hsu et al.8
described that surgery for thymic carcinoma is the primary
treatment, and the prognosis of the patients who received a
complete resection was found to be better than for those who
received an incomplete resection. Currently, those references
FIGURE 3. A, Microscopic findings shows the tumor cells
to be floating in pools of extracellular mucin with little
stroma (H&E stain, A 40). B, The tumor cells produced
abundant extracellular mucin (H&E stain, B 400).
TABLE 1. Summary of Previous Reports and the Current Case of Mucinous Adenocarcinomas of the Thymus
Author Year Age/sex Treatment Outcome
Immunoreactivity
CD 5 CD 7 CD 20
Ra et al.1 (two cases) 2007 61/F Resection  RTx Alive with disease at 5 mo   
82/F Resection Died of complication   
Kapur et al.2 2006 41/M Resection  RTx Alive and well at 44 mo   
Takahashi et al.3 2005 59/M RTx Died of disease at 11 mo   
Seki et al.4 2004 34/F Resection Died of disease at 20 mo ND ND ND
Choi et al.5 2003 15/M Resection  RTx Died of disease at 26 mo   
The current case 49/M Resection  RTx  CTx Alive with disease at 11 mo   
M, male; F, female; RTx, Radiotherapy; CTx, Chemotherapy; , negative; , positive; ND, not done.
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all stated that a complete resection is a factor which indicates
a good prognosis,9 and Masaoka’s staging system is therefore
useful for determining which modality should be chosen.
Thymic carcinoma has a poor prognosis and a reported
overall 5 year survival rate of 14.5 to 34.4%.10–11 Suster and
Rosai11 stated that thymic carcinoma can be divided into two
histologic types (low-grade malignancy and high-grade ma-
lignancy) and there was a significant difference between
them. There are many references that the prognosis of pa-
tients with squamous-cell subtype is favorable,11 so that
histologic type of thymic carcinoma may thus a possible
prognostic factor. The outcomes of the previous six cases of
the mucinous subtype show that three cases were fatal and a
poor prognosis is likely. In this case, however, adjuvant
therapy was conducted, and the pleural dissemination contin-
ued 11 months after surgery.
In conclusion, a rare case of mucinous adenocarcinoma of
the thymus was observed and the patient received multimodality
treatment. Further clinicopathologic and genetic analysis may
lead to a better understanding of this uncommon disease.
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